PMC:7784786 / 6822-7094
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 236 | 21-31 | Chemical | denotes | itolizumab | MESH:C000597346 |
| 237 | 148-158 | Chemical | denotes | itolizumab | MESH:C000597346 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T62 | 0-272 | Sentence | denotes | Patient 3 (C) Before itolizumab (D0): alveolar interstitial inflammatory infiltrate in both lung fields, predominantly on the right side. (D) After itolizumab (48 h): radiological improvement with significant decrease of the alveolar interstitial infiltrate of both lungs. |